257 related articles for article (PubMed ID: 27773451)
1. Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
Gavalas MV; Breskin A; Yuzefpolskaya M; Eisenberger A; Castagna F; Demmer RT; Flannery M; Garan AR; Takeda K; Takayama H; Naka Y; Topkara VK; Colombo PC
J Heart Lung Transplant; 2017 Jan; 36(1):59-63. PubMed ID: 27773451
[TBL] [Abstract][Full Text] [Related]
2. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
[TBL] [Abstract][Full Text] [Related]
3. Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis.
Bartoli CR; Zhang D; Kang J; Hennessy-Strahs S; Restle D; Howard J; Redline G; Bermudez C; Atluri P; Acker MA
Ann Thorac Surg; 2018 Mar; 105(3):807-814. PubMed ID: 28942075
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support.
Shah P; Mehta VM; Cowger JA; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):102-4. PubMed ID: 23968811
[No Abstract] [Full Text] [Related]
5. Clinical implications of LDH isoenzymes in hemolysis and continuous-flow left ventricular assist device-induced thrombosis.
Gordon JS; Wood CT; Luc JGY; Watson RA; Maynes EJ; Choi JH; Morris RJ; Massey HT; Throckmorton AL; Tchantchaleishvili V
Artif Organs; 2020 Mar; 44(3):231-238. PubMed ID: 31494952
[TBL] [Abstract][Full Text] [Related]
6. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.
Uriel N; Han J; Morrison KA; Nahumi N; Yuzefpolskaya M; Garan AR; Duong J; Colombo PC; Takayama H; Thomas S; Naka Y; Jorde UP
J Heart Lung Transplant; 2014 Jan; 33(1):51-9. PubMed ID: 24290832
[TBL] [Abstract][Full Text] [Related]
7. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
[TBL] [Abstract][Full Text] [Related]
8. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.
Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S
J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733
[TBL] [Abstract][Full Text] [Related]
9. A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy.
Katz JN; Jensen BC; Chang PP; Myers SL; Pagani FD; Kirklin JK
J Heart Lung Transplant; 2015 May; 34(5):701-9. PubMed ID: 25582036
[TBL] [Abstract][Full Text] [Related]
10. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
[TBL] [Abstract][Full Text] [Related]
11. Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends.
Hurst TE; Xanthopoulos A; Ehrlinger J; Rajeswaran J; Pande A; Thuita L; Smedira NG; Moazami N; Blackstone EH; Starling RC
ESC Heart Fail; 2019 Oct; 6(5):1005-1014. PubMed ID: 31318170
[TBL] [Abstract][Full Text] [Related]
12. Increased Plasma-Free Hemoglobin Levels Identify Hemolysis in Patients With Cardiogenic Shock and a Trans valvular Micro-Axial Flow Pump.
Esposito ML; Morine KJ; Annamalai SK; O'Kelly R; Aghili N; Pedicini R; Breton C; Mullin A; Hamadeh A; Kiernan MS; DeNofrio D; Kapur NK
Artif Organs; 2019 Feb; 43(2):125-131. PubMed ID: 30216467
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Pre-Explant Lactate Dehydrogenase Concentrations and Findings During Post-Explant Pump Analysis of the HeartMate II Left Ventricular Assist Device.
Sood V; Alam O; Tchantchaleishvili V; Pagani FD; Aaronson KD; Haft J; Joyce DL; Joyce LD; Daly RC; Maltais S; Stulak JM
Ann Thorac Surg; 2017 Apr; 103(4):1207-1213. PubMed ID: 27743635
[TBL] [Abstract][Full Text] [Related]
14. Lactic Dehydrogenase in the In Vitro Evaluation of Hemolytic Properties of Ventricular Assist Device.
Li D; Wu Q; Liu S; Chen Y; Chen H; Ruan Y; Zhang Y
Artif Organs; 2017 Nov; 41(11):E274-E284. PubMed ID: 28722142
[TBL] [Abstract][Full Text] [Related]
15. Single-Center Experience With HeartMate II Left Ventricular Assist Device Explantation.
Tchantchaleishvili V; Cheyne C; Sherazi S; Melvin AL; Hallinan W; Chen L; Todd Massey H
Artif Organs; 2016 Dec; 40(12):1145-1149. PubMed ID: 27076358
[TBL] [Abstract][Full Text] [Related]
16. Unexpected abrupt increase in left ventricular assist device thrombosis.
Starling RC; Moazami N; Silvestry SC; Ewald G; Rogers JG; Milano CA; Rame JE; Acker MA; Blackstone EH; Ehrlinger J; Thuita L; Mountis MM; Soltesz EG; Lytle BW; Smedira NG
N Engl J Med; 2014 Jan; 370(1):33-40. PubMed ID: 24283197
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow left ventricular assist device support.
Jennings DL; Williams CT; Morgan JA
ASAIO J; 2013; 59(5):526-7. PubMed ID: 23896772
[TBL] [Abstract][Full Text] [Related]
18. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.
Fine NM; Topilsky Y; Oh JK; Hasin T; Kushwaha SS; Daly RC; Joyce LD; Stulak JM; Pereira NL; Boilson BA; Clavell AL; Edwards BS; Park SJ
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1129-40. PubMed ID: 24094831
[TBL] [Abstract][Full Text] [Related]
19. Are elevated serum haemolysis markers a harbinger of adverse events in HeartMate II patients?
Zayat R; Shoaib M; Khattab MA; Ahmad U; Goetzenich A; Stoppe C; Foldenauer AC; Moza A; Schnoering H; Autschbach R; Tewarie L
Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):5-12. PubMed ID: 29444250
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte aging as a mechanism of anemia and a biomarker of device thrombosis in continuous-flow left ventricular assist devices.
Taimeh Z; Koene RJ; Furne J; Singal A; Eckman PM; Levitt MD; Pritzker MR
J Heart Lung Transplant; 2017 Jun; 36(6):625-632. PubMed ID: 28396088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
